Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
$19.82
-1.9%
$17.69
$4.66
$34.05
$77.46M1.66134,027 shs924,904 shs
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$9.67
-3.0%
$9.21
$5.45
$18.98
$329.82M1.9204,925 shs161,042 shs
OpGen, Inc. stock logo
OPGN
OpGen
$0.00
$2.58
$0.00
$0.00
$1K-1.77596 shs285 shs
TruBridge, Inc. stock logo
TBRG
TruBridge
$19.90
-0.3%
$20.99
$11.39
$32.00
$299.48M0.5579,885 shs152,461 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
+2.02%+5.59%+23.16%+25.61%+42.42%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-3.01%+3.31%+8.77%-13.89%+36.58%
OpGen, Inc. stock logo
OPGN
OpGen
0.00%0.00%0.00%-100.00%-100.00%
TruBridge, Inc. stock logo
TBRG
TruBridge
-0.25%0.00%+3.70%-16.28%+64.87%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
$19.82
-1.9%
$17.69
$4.66
$34.05
$77.46M1.66134,027 shs924,904 shs
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$9.67
-3.0%
$9.21
$5.45
$18.98
$329.82M1.9204,925 shs161,042 shs
OpGen, Inc. stock logo
OPGN
OpGen
$0.00
$2.58
$0.00
$0.00
$1K-1.77596 shs285 shs
TruBridge, Inc. stock logo
TBRG
TruBridge
$19.90
-0.3%
$20.99
$11.39
$32.00
$299.48M0.5579,885 shs152,461 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
+2.02%+5.59%+23.16%+25.61%+42.42%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-3.01%+3.31%+8.77%-13.89%+36.58%
OpGen, Inc. stock logo
OPGN
OpGen
0.00%0.00%0.00%-100.00%-100.00%
TruBridge, Inc. stock logo
TBRG
TruBridge
-0.25%0.00%+3.70%-16.28%+64.87%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
0.00
N/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.83
Moderate Buy$16.6071.66% Upside
OpGen, Inc. stock logo
OPGN
OpGen
0.00
N/AN/AN/A
TruBridge, Inc. stock logo
TBRG
TruBridge
2.50
Moderate Buy$21.256.78% Upside

Current Analyst Ratings Breakdown

Latest MGEN, OPGN, NPCE, and TBRG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/13/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
8/13/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$17.00 ➝ $15.00
(Data available from 9/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
$4.46M17.37N/AN/A$6.78 per share2.92
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$79.91M4.00N/AN/A$0.27 per share35.81
OpGen, Inc. stock logo
OPGN
OpGen
$2.67M0.00N/AN/A($11.55) per share0.00
TruBridge, Inc. stock logo
TBRG
TruBridge
$339.17M0.88$1.91 per share10.41$11.30 per share1.76
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
-$41.87M-$20.09N/AN/AN/A-1,393.50%-141.66%-88.74%N/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$27.14M-$0.84N/AN/AN/A-29.29%-168.61%-25.48%11/11/2025 (Estimated)
OpGen, Inc. stock logo
OPGN
OpGen
-$32.67MN/A0.00N/A-1,140.36%N/A-287.58%11/13/2025 (Estimated)
TruBridge, Inc. stock logo
TBRG
TruBridge
-$19.67M-$0.84N/A14.32N/A-3.63%3.30%1.43%11/6/2025 (Estimated)

Latest MGEN, OPGN, NPCE, and TBRG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q2 2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$0.24-$0.26-$0.02-$0.26$23.08 million$23.52 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
N/AN/AN/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
N/AN/AN/AN/AN/A
OpGen, Inc. stock logo
OPGN
OpGen
N/AN/AN/AN/AN/A
TruBridge, Inc. stock logo
TBRG
TruBridge
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
0.20
4.23
4.23
NeuroPace, Inc. stock logo
NPCE
NeuroPace
3.02
5.47
4.51
OpGen, Inc. stock logo
OPGN
OpGen
N/A
5.45
5.45
TruBridge, Inc. stock logo
TBRG
TruBridge
0.94
1.80
1.79

Institutional Ownership

CompanyInstitutional Ownership
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
N/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
78.83%
OpGen, Inc. stock logo
OPGN
OpGen
2.68%
TruBridge, Inc. stock logo
TBRG
TruBridge
88.64%

Insider Ownership

CompanyInsider Ownership
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
1.10%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
20.50%
OpGen, Inc. stock logo
OPGN
OpGen
43.80%
TruBridge, Inc. stock logo
TBRG
TruBridge
10.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
453.91 millionN/ANot Optionable
NeuroPace, Inc. stock logo
NPCE
NeuroPace
17033.08 million26.30 millionOptionable
OpGen, Inc. stock logo
OPGN
OpGen
10010.07 million4.70 millionNot Optionable
TruBridge, Inc. stock logo
TBRG
TruBridge
3,20015.01 million13.41 millionOptionable

Recent News About These Companies

Return Trends At TruBridge (NASDAQ:TBRG) Aren't Appealing
TruBridge, Inc. (TBRG) Q2 2025 Earnings Call Transcript
TruBridge Announces Second Quarter 2025 Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Miragen Therapeutics stock logo

Miragen Therapeutics NASDAQ:MGEN

Miragen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing proprietary RNA-targeted therapies with a specific focus on microRNAs and their role in diseases where there is a high-unmet medical need. Its four lead product candidates include cobomarsen, an inhibitor of miR-155 for treating various blood cancers, such as cutaneous T-cell lymphoma, adult T-cell lymphoma/leukemia, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia; Remlarsen, a replacement for miR-29, a microRNA that is found at abnormally low levels in various pathological fibrotic conditions, including cutaneous and ocular fibrosis, which is in Phase II clinical trial; MRG-229, which is in preclinical trial for the treatment of idiopathic pulmonary fibrosis; and MRG- 110, an inhibitor of miR-92, a microRNA expressed in endothelial cells, which has completed two Phase I clinical trial for the treatment of heart failure, wound healing, and other ischemic disease in the United States and Japan. Miragen Therapeutics, Inc. was founded in 2006 and is based in Boulder, Colorado.

NeuroPace stock logo

NeuroPace NASDAQ:NPCE

$9.67 -0.30 (-3.01%)
Closing price 09/10/2025 04:00 PM Eastern
Extended Trading
$9.61 -0.06 (-0.66%)
As of 04:31 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

OpGen stock logo

OpGen NASDAQ:OPGN

$0.0001 0.00 (0.00%)
As of 09/9/2025 09:41 AM Eastern

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. It also utilizes molecular diagnostics and informatics to help combat infectious diseases. The company helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.

TruBridge stock logo

TruBridge NASDAQ:TBRG

$19.90 -0.05 (-0.25%)
Closing price 09/10/2025 04:00 PM Eastern
Extended Trading
$19.91 +0.01 (+0.05%)
As of 09/10/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence. The company provides acute care solutions and related services for community hospitals, and physician clinics; and patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. In addition, it offers patient liability estimates eligibility verification, claim scrubbing and submission, remittance management, denial/audit management, and contract management; and offers RCM services, such as accounts receivable management, private pay service, medical coding, revenue cycle consulting, and other additional insurance and patient billing services. Further, it offers consulting and business management services; managed IT services; encoder solutions; patient management; financial accounting; clinical; patient care; and enterprise applications. Additionally, it offers TruBridge HER platform, including total system support, national client conference, continuing education, software releases, hardware replacement, cloud electronic health record, forms and supplies, and public cloud infrastructure services; post-acute care software systems, and support and maintenance services; and InstantPHR, an interactive portal and CHBase which funnels data from multiple sources into one platform. The company was formerly known as Computer Programs and Systems, Inc. and changed its name to TruBridge, Inc. in March 2024. TruBridge, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.